Christopher P. Kiritsy, Director at PIERIS PHARMACEUTICALS, INC. (PIRS), bought 10,000 shares at $0.85 ($9K) on 2023-05-25, disclosed to the SEC on 2023-05-30.
Open-market purchase of $8k PIRS by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Clearly above the average filing.
| Filing → |